
|Articles|November 11, 2022
Castor Launches Real-World Evidence Offering
Offering includes pre-configured modules for patient recruitment, eligibility screening, enrollment, data capture, and participant engagement.
Advertisement
Castor has announced the launch of a new real-world evidence offering. The offering, Castor Real-World Evidence (RWE), provides integrated technology and services to accelerate the collection of RWD for PMCT.
Read more about the new offering
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Imfinzi Regimen Demonstrates 22% Survival Benefit in Early Gastric and GEJ Cancer
2
Thermo Fisher, Lundbeck Announce New OpenAI Partnerships Advancing AI in Drug Development
3
Reducing Site Burden Through Better Technology Integration in Clinical Trials
4
ACT Brief: AI Partnerships, Data-Driven Site Activation, and FDA Approval for Omvoh’s Single-Injection Regimen
5






.png)



.png)



.png)
.png)
